Abstract:Early percutaneous rheolytic thrombectomy (RT) can potentially decrease the risk of post-thrombotic syndrome (PTS) by restoring venous patency and preserving valvular function by rapid clot remove. Direct iliofemoral stenting or staged stenting with catheter-directed thrombolysis (CDT) after AngioJet RT is still a matter of debate. This study was undertaken to compare the efficacy and treatment outcomes of patients with acute proximal deep vein thrombosis (DVT) of the lower limb accompanied with iliofemoral stenosis who underwent direct or staged stenting with CDT after RT. Ninety-one patients with acute proximal DVT of the lower limb who were diagnosed by ultrasound imaging were divided into two treatment groups: one group received direct stenting after RT, and the other received staged stenting after RT+CDT. Comparisons were made with regards to the treatment outcome between the two groups. Venous Registry Index was used to evaluate the postprocedural patency, and PTS was assessed using the Villalta scale. Forty-six patients in direct group and 45 in the staged group were followed up for 1 year. The technical success was 100% in both groups, without any 30-day mortality. Recurrent DVT was occurred in two patients in direct group.VRI changed from 11.68 ± 1.92 preoperatively to 3.21 ± 1.44 postoperatively in the direct group and from 12.17 ± 2.29 to 2.36 ± 1.19 in the staged group. The thrombolysis rate was 81.50 ± 5.76 and 85.67 ± 3.84 in the direct and staged groups, respectively (P < .01; Table I). There were no differences in complications, thrombus score, and VRI between the two groups. Immediate (24 hours) improvement in clinical symptoms in direct and staged groups was achieved in 42 (81%) and 33 (72%) cases, respectively (not significant). Significant reductions in hospital lengths of stay were noted in the direct group (4.59 ± 0.91) when compared to the staged group (5.8 ± 1.6). The Villalta scale was 4.20 ± 2.47 in the direct group and 2.13 ± 1.91 in the staged group (P < .001). Primary patency rate at 1 year was 93.5% in the direct group and 97.8% in the staged group (P = .323; Table II). Both direct and staged stenting are effective treatment modalities in patients with acute proximal DVT. Compared with staged, direct provides similar treatment success and significant reductions in hospital lengths of stay but with more risk of PTS at 1-year follow-up.Table IPatient demographic and treatment outcome in the treatment groupsVariableDirect therapy (n = 46)Staged therapy (n = 45)P valueAge, mean y54.856.5NSMale, No. (%)32 (69)27 (60)NSThrombolysis grade, No.NS 131 22623 32325Immediate clinical improvement, No. (%)43 (93)31 (69%)<.001Overall hospital length of stay, days4.59 ± 0.915.8 ± 1.6<.001NS, Not significant. Open table in a new tab Table IIClinical outcomesOutcomeDirect therapy (n = 46)Staged therapy (n = 45)P valueComplication00NS Major bleeding00NS Minor bleeding01NS Pulmonary embolism00NS Renal failure00NS 30-day mortality00NS Recurrent DVT20NSPostprocedural patency (VRI) Preoperation11.68 ± 1.9212.17 ± 2.29.194 Postoperation3.21 ± 1.442.36 ± 1.19.0000Thrombolysis rate (%)81.50 ± 5.7685.67 ± 3.84.000012-month clinical outcome Venous reflux1.36 ± 0.461.26 ± 0.41.139 Villalta scale4.20 ± 2.472.13 ± 1.91.0001NS, Not significant; VRI, venous Registry Index. Open table in a new tab

FT21. Comparison of Direct Iliofemoral Stenting with Staged Stenting after AngioJet Rheolytic Thrombectomy in Patients with Acute Deep Vein Thrombosis